NCT03392467View on ClinicalTrials.gov

PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

January 9, 2024

Study Completion Date

October 18, 2024

Conditions
Severe Bronchopulmonary Dysplasia
Interventions
BIOLOGICAL

PNEUMOSTEM

human umbilical cord blood-derived mesenchymal stem cells

OTHER

Placebo

normal saline

Trial Locations (2)

Unknown

Asan medical Center, Seoul

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Medipost Co Ltd.

INDUSTRY

NCT03392467 - PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants | Biotech Hunter | Biotech Hunter